Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corp (NQ: MASI )

126.72 -0.46 (-0.36%)
Streaming Delayed Price Updated: 10:12 AM EDT, May 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Masimo Corp

< Previous 1 2 3 4 5 6 7 8 9 Next >
Masimo Launches Dual SET® Pulse Oximetry
From Masimo
Via Business Wire
Masimo Reports Third Quarter 2021 Financial Results
From Masimo
Via Business Wire
New Study Recommends the Use of Masimo PVi® to Guide Fluid Administration During Major Oncosurgery with Lung Ultrasonography
From Masimo
Via Business Wire
Masimo to Report Third Quarter 2021 Financial Results After Market Close on Tuesday, October 26
From Masimo
Via Business Wire
Masimo and University Hospitals Partner to Combat Nurse Burnout
From Masimo
Via Business Wire
New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates
From Masimo
Via Business Wire
Masimo CEO Joe Kiani Appointed to President’s Council of Advisors on Science and Technology
From Masimo
Via Business Wire
Masimo Launches Single-patient-use rainbow® SuperSensor™
From Masimo
Via Business Wire
Masimo to Present in Morgan Stanley 19th Annual Global Healthcare Conference
From Masimo Corporation
Via Business Wire
New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients
From Masimo
Via Business Wire
Masimo Partners with Penington Institute to Raise Awareness of Harm from Prescription Opioid Overdose
From Masimo
Via Business Wire
Masimo SafetyNet Alert™ Launches in Western Europe
From Masimo
Via Business Wire
Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring
From Masimo
Via Business Wire
New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneously Breathing Hemodialysis Patients
From Masimo
Via Business Wire
New Study Evaluates the Use of Masimo Bridge® As an Alternative to Opioids
From Masimo
Via Business Wire
Masimo Reports Second Quarter 2021 Financial Results
From Masimo
Via Business Wire
Masimo Introduces the MX-7™ rainbow SET® Technology Board for Original Equipment Manufacturing Partners
From Masimo
Via Business Wire
Masimo to Report Second Quarter 2021 Financial Results after Market Close on Tuesday, July 27
From Masimo
Via Business Wire
New Study Evaluates the Ability of Masimo SedLine® Brain Function Monitoring to Predict Neurological Outcomes and Long-term Survival in Post-Cardiac Arrest ICU Patients
From Masimo
Via Business Wire
Masimo Announces FDA 510(k) Clearance of Radius Tº™ for Prescription and Over-the-Counter (OTC) Use
From Masimo
Via Business Wire
New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-Mediated Morbidity During One-Lung Ventilation
From Masimo
Via Business Wire
Masimo to Present in UBS Global Healthcare Virtual Conference
From Masimo
Via Business Wire
New Study Assesses the Effects of Masimo Patient SafetyNet™ on Nursing Workflows in the General Ward
From Masimo
Via Business Wire
Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality
From Masimo
Via Business Wire
Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy
From Masimo
Via Business Wire
Masimo Reports First Quarter 2021 Financial Results
From Masimo
Via Business Wire
Masimo Reschedules Date of First Quarter 2021 Financial Results Conference Call
From Masimo
Via Business Wire
Masimo to Report First Quarter 2021 Financial Results after Market Close on Tuesday, April 27
From Masimo
Via Business Wire
Masimo Announces FDA Clearance of Radius PCG™ for the Root® Patient Monitoring and Connectivity Platform
From Masimo
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.